Showing posts with label UCLA. Show all posts
Showing posts with label UCLA. Show all posts

Monday, May 25, 2009

A Genetic Clue to Why Autism Affects Boys More

Autism

Ten year-old Tristan Bonnert, who has autism, with his mother Delilah at their home in Columbia, S.C. - Mary Ann Chastain / AP

Among the many mysteries that befuddle autism researchers: why the disorder affects boys four times more often than girls. But in new findings reported online today by the journal Molecular Psychiatry, researchers say they have found a genetic clue that may help explain the disparity.

The newly discovered autism-risk gene, identified by authors as CACNA1G, is more common in boys than in girls (why that's so is still not clear), and the authors suggest it plays a role in boys' increased risk of the developmental disorder. CACNA1G, which sits on chromosome 17, amid other genes that have been previously linked to autism, is responsible for regulating the flow of calcium into and out of cells. Nerve cells in the brain rely on calcium to become activated, and research suggests that imbalances in the mineral can result in the overstimulation of neural connections and create developmental problems, such as autism and even epilepsy, which is also a common feature of autism. (See six tips for traveling with an autistic child.)

"Our current theories about autism suggest that the disorder is related to overexcitability at nerve endings," says Geri Dawson, chief science officer of Autism Speaks, an advocacy group that provided the genetic data used by the study's authors. "It's interesting to see that the gene they identified appears to modulate excitability of neurons."

For the new study, researchers at the University of California, Los Angeles (UCLA), combed the genetic database of the Autism Genetic Resource Exchange (AGRE), a resource of DNA from 2,000 families with at least one autistic child. The scientists focused on the more than 1,000 genetic samples of families in which at least one son was affected by the disorder, prompted by the results of an earlier study using the same database, which identified a rich autism-related genetic region on chromosome 17 that contained genetic variants more common in boys than in girls. While nearly 40% of the general population has the most common form of CACNA1G, one variant of the gene was more prevalent in autistic boys, researchers found. "There is a strong genetic signal in this region," says Dr. Daniel Geschwind, director of UCLA's Center for Autism Research and Treatment and one of the study's co-authors. "But this gene doesn't explain all of that signal or even half of it. What that means is that there are many more genes in this region contributing to autism." (See pictures of inside a school for autistic children.)

That's not surprising for a disorder as complex as autism — actually, a spectrum of developmental disorders involving impairment in language, social behavior and certain physical behaviors — with symptoms that range widely in number and severity. So far, studies have linked a handful of genes, all of which play a role in the way nerve cells connect and communicate, with autism spectrum disorders. It's likely not only that a large number of genes contribute to the disorder, but also that a different combination of genes — as well as unique interactions between genes and environment — are responsible for each individual case of autism.

So it's certainly a daunting challenge to begin teasing out the individual genes that may contribute to autism, as the UCLA team has with CACNA1G, but databases like AGRE make the job slightly easier. The next step will be to try to use known autism genes to help develop screening tools or early interventions. "We are going to have a much better understanding of the causes of autism over the next five to 10 years," says Dawson. "We're in a period of great discovery."

By ALICE PARK Tuesday, May. 19, 2009

Source: Time Magazine

Posted: Ask Marion – TrueHealthisTrueWealth

Related Articles:

A Link Between Autism and Testosterone?

Six Tips for Traveling with an Autistic Child

Inside a School for Autistic Children

Monday, September 29, 2008

Statins Can Hinder Muscle Repair

Statins, taken by millions to lower cholesterol, may hinder the body's ability to repair muscles, University of Alabama researchers report.

The most frequently reported side effect of statin therapy is fatigue, with about 9 percent of patients reporting muscle pain. As doses of the medication are increased, and physical activity is added, these effects can be more pronounced. These side effects are found in all commonly used statins.

"While these are preliminary data and more research is necessary, the results indicate serious adverse effects of statins that may alter the ability of skeletal muscle to repair and regenerate due to the anti-proliferative effects of statins," lead researcher Anna Thalacker-Mercer said in a statement.

Results of the study were presented Thursday at a meeting of the American Physiological Society, in Hilton Head, S.C.

For the study, Thalacker-Mercer's team exposed muscle cells to varying doses of Simvastatin.

The researchers found as the dosage increased, the ability of these cells to multiply decreased. For the equivalent of 40 milligrams a day, growth of new muscle cells was reduced by 50 percent.

When doses were increased, proliferation of these cells continued to decline to the point where they could have a negative affect on the ability of muscles to heal and repair themselves, the researchers found.

"We are very interested in these effects in the older population," Thalacker-Mercer said. "It is possible that older adults may not be able to distinguish between muscle pain related to a statin effect or an effect of aging, and therefore adverse effects of statins in older adults may be under-reported. Therefore, our next step is to examine statins among older adults," she said.

Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles, (UCLA) thinks that this research may lead to ways of preventing muscle damage in patients taking statins.

"Statins are among the most extensively studied medications and provide cardiovascular benefits that greatly outweigh potential risks in most patients," Fonarow stressed.

Between 2 percent and 8 percent of patients report having muscle aches in response to statins, Fonarow noted. "Significant muscle damage as result of statin treatment rarely occurs, but if it does, there can be serious consequences," he noted.

This study suggests that high doses of a statin may alter the ability of skeletal muscle cells to repair and regenerate, Fonarow said. "This research may eventually lead to new ways to minimize or prevent statin-induced muscle damage," he added.

By Steven Reinberg
HealthDay Reporter, Copyright © 2008 ScoutNews LLC

More information

For more about statins, visit the American Heart Association.

Study: Lipitor ads may mislead women

(Journal of Empirical Legal Studies) UPDATED 2008-09-05
Researchers say that though the cholesterol-lowering drug Lipitor has long been marketed to both men and women, they have been unable to find adequate scientific evidence that the drug actually helps women lower their risk of having a heart attack. The investigators also found that Pfizer, the company that makes Lipitor, does not include portions of the drug's approved label in its advertisements. This allows the ads to omit clinical trial evidence that has shown a slightly increased heart attack risk in women who took Lipitor. The researchers say their findings suggest that the U.S. Food and Drug Administration may not be providing adequate regulation of Lipitor, the world's best-selling drug.  Read full story:  See all at Heart Disease News